BPC-157 / TB-500 / GHK-Cu.
Three of the most studied repair peptides combined for connective tissue, skin, and soft-tissue support.
3 mg / 3 mg / 10 mg per mL · single-vial injectablePricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients recovering from surgery, particularly cosmetic procedures
- Patients with both joint or muscle injuries and skin or scar concerns
- Patients wanting an integrated recovery + skin renewal protocol
- Active patients who want collagen support alongside tissue repair
This isn't for you if
Investigational combination. Not appropriate during pregnancy, breastfeeding, or with active malignancy. GHK-Cu and components have been subject to ongoing FDA regulatory review.
BPC-157 / TB-500 / GHK-Cu
This three-peptide combination pairs the Wolverine base (BPC-157 + TB-500) with GHK-Cu, a copper-binding tripeptide studied for collagen synthesis and tissue remodeling. It's used when patients want both soft-tissue recovery and skin or scar improvement in one protocol.
Mechanism and fit.
BPC-157 calms inflammation and signals tissue repair. TB-500 supports circulation and cell migration. GHK-Cu directly signals fibroblasts to produce collagen and elastin while improving microcirculation. Together, the combination addresses the deep tissue and the surface in one nightly injection.
Who this is typically for.
- Patients recovering from surgery, particularly cosmetic procedures
- Patients with both joint or muscle injuries and skin or scar concerns
- Patients wanting an integrated recovery + skin renewal protocol
- Active patients who want collagen support alongside tissue repair
What patients
most often ask.
Is this overkill if I just have a torn tendon?
For an isolated tendon injury, the simpler Wolverine Stack is usually sufficient. This three-peptide combination earns its place when there's a meaningful skin, scar, or connective-tissue cosmetic component as well.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients recovering from surgery, particularly cosmetic procedures</li><li>Patients with both joint or muscle injuries and skin or scar concerns</li><li>Patients wanting an integrated recovery + skin renewal protocol</li><li>Active patients who want collagen support alongside tissue repair</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingOnce daily, provider-directed, 5 days on / 2 days off.
- Typical duration6–8 weeks per cycle.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering BPC-157 / TB-500 / GHK-Cu, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.